Endorsed by influential Asia-Pacific oncology associations, the ESMO Asia Congress 2024 is an important platform in the region for the presentation of the latest practice-changing studies in cancer care and state-of-the-art education.
ESMO thanks the following endorsing societies who have already confirmed their support to the ESMO Asia Congress 2024, and encourages all oncology professionals, including members of these societies, to register for ESMO Asia Congress 2024 and enjoy its fully featured scientific and educational programme.
- Medical Oncology Group of Australia
- Oncology Club, Bangladesh
- Chinese Society of Clinical Oncology
- Hong Kong Cancer Therapy Society
- Indian Society of Medical & Paediatric Oncology
- Indonesian Society of Hematology Medical Oncology
- Iranian Society of Clinical Oncology
- Iranian Society of Medical Oncology and Hematology
- Japan Society of Clinical Oncology
- Japanese Society of Medical Oncology
- Kazakhstan Cancer Society
- Korean Society of Medical Oncology
- Malaysian Oncological Society
- Myanmar Oncology Society
- New Zealand Society for Oncology
- Pakistan Society of Clinical Oncology
- Philippine Society of Medical Oncology
- Singapore Society of Oncology
- Taiwan Oncology Society
- Thai Society of Clinical Oncology
- Association of Oncologists of Uzbekistan
- Viet Nam Cancer Association